Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
R Bono, G Sapienza, S Tringali, C Rotolo, C Patti… - Cells, 2024 - mdpi.com
Refractory acute myeloid leukaemia is very difficult to treat and represents an unmet clinical
need. In recent years, new drugs and combinations of drugs have been tested in this …
need. In recent years, new drugs and combinations of drugs have been tested in this …
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society …
Older adults with acute myeloid leukemia (AML) refractory to initial or reinduction
chemotherapy have a dismal prognosis if they do not undergo hematopoietic stem-cell …
chemotherapy have a dismal prognosis if they do not undergo hematopoietic stem-cell …
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission
M Yanada, S Yamasaki, T Kondo, T Kawata, K Harada… - Leukemia, 2024 - nature.com
Allogeneic hematopoietic cell transplantation (HCT) is the last option for long-term survival
for patients with chemotherapy-refractory acute myeloid leukemia (AML). By using the …
for patients with chemotherapy-refractory acute myeloid leukemia (AML). By using the …
Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with …
HLA-haploidentical allogeneic hematopoietic stem cell transplantation (Haplo-HCT) is
frequently used as treatment for patients with active acute myeloid leukemia (AML). Here, we …
frequently used as treatment for patients with active acute myeloid leukemia (AML). Here, we …
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
The intensity of the conditioning regimen given before allogeneic hematopoietic cell
transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently …
transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently …
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group …
T Heinicke, R Krahl, C Kahl, M Cross, S Scholl… - Annals of …, 2021 - Springer
Relapse of acute leukemia is a frequent complication with uncertain outcome and poorly
defined risk factors. From 1621 patients entered into two prospective clinical trials (AML02; …
defined risk factors. From 1621 patients entered into two prospective clinical trials (AML02; …
Effective immunosurveillance after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
The number of patients receiving allogeneic hematopoietic stem cell transplantation
(alloHCT) has increased constantly over the last years due to advances in transplant …
(alloHCT) has increased constantly over the last years due to advances in transplant …
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life …
C Yan, Y Wang, Y Sun, Y Cheng, X Mo… - Cancer …, 2022 - Wiley Online Library
Background Patients with refractory or relapsed acute myeloid leukemia (AML) have poor
survival, necessitating the exploration of optimized therapeutic strategy. Here, we aimed to …
survival, necessitating the exploration of optimized therapeutic strategy. Here, we aimed to …
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia
J Ronnacker, MA Urbahn, C Reicherts… - British Journal of …, 2024 - Wiley Online Library
For patients with relapsed or refractory AML, sequential conditioning prior to allogeneic stem
cell transplantation (alloSCT) is an established and potentially curative treatment option …
cell transplantation (alloSCT) is an established and potentially curative treatment option …
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO …
The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment
represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) …
represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) …